
Sign up to save your podcasts
Or
Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831
4.6
77 ratings
Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831
288 Listeners
39 Listeners
4 Listeners
55 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
4 Listeners
26 Listeners
41 Listeners
14 Listeners
1 Listeners
46 Listeners
0 Listeners
6 Listeners
14 Listeners
43,414 Listeners
111,261 Listeners
14 Listeners
3 Listeners
27 Listeners
23 Listeners
132 Listeners
182 Listeners
2 Listeners
0 Listeners
0 Listeners